FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989892009> ?p ?o ?g. }

• W1989892009 abstract "Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, ILGenistein is a soybean-derived isoflavone with antioxidant and anti-inflammatory effects. It also has tyrosine kinase inhibitory properties that attenuates proliferation of both normal and cancerous cells. Patients with severe congenital neutropenia (SCN) require continuous G-CSF treatment throughout their lifetime. Such prolonged treatment increases the incidence of myelodysplastic syndromes/acute myeloid leukemia (MDS/AML) in this population. We hypothesize that genistein could counteract the deleterious effects of excessive hematopoietic stem cell (HSC) proliferation, which can lead to DNA damage, increase in radical oxygen species (ROS) production and DNA instability. To test our hypothesis we choose the p53 heterozygous (+/−) mouse model, once those animals have a constitutive enhancement in HSC proliferation. They also display high levels of ROS and DNA damage in comparison to wild type (WT). We started our experiments treating WT and p53+/− mice 3 times a week with subcutaneous injections of genistein. After treatment, we analyzed the total number of lin-ckit+sca+ (KLS) cells. The number of p53+/− KLS decreased while the WT KLS numbers remained unaffected. KLS cells were then analyzed for the amount of DNA damage via nuclear pH2AX staining. Our results show a 2 fold decrease in DNA damage on the p53+/− cells from treated animals, compared to untreated ones, while the levels of DNA damage remained unaltered on WT. Basal levels of ROS on p53+/− KLS cells were higher than in the WT KLS cells, but after treated with genistein those levels decreased by 10 fold. Interestingly, long term treatment with genistein did not result in a decrease of white blood cells on neither p53+/− nor WT animals. To elucidate the mechanism of action, KLS cells were sorted and cell cycle analyses showed that genistein inhibited cell cycle specifically in the stem cell population. Genistein reduced the percentage of p53+/− KLS cells in cycle, but it had no effect on WT cells. We then tested genistein effects on HSC population in bone marrow competitive repopulation assay. We transplanted lethally irradiated mice with a 50:50 mix of bone marrow from WT and p53+/− mice. After the transplant the animals were treated 3 times a week with subcutaneous injections of genistein or adjuvant. Animals were euthanized after 5 weeks of treatment and blood and bone marrow were analyzed. After genistein treatment, the percentages of p53+/− KLS cells in bone marrow were 60% on treated mice and 80% on untreated mice. This data suggests that genistein preferentially inhibits the highly proliferative stem cell population, indicating its preventive or therapeutic potential against the deleterious effects of excessive HSC proliferation. Understanding this mechanism of action could potentially reveal novel treatments for patients suffering with severe congenital neutropenia, leukemia, or other hematological malignancies with route on excessive HCS proliferation.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3489. doi:1538-7445.AM2012-3489" @default.
• W1989892009 created "2016-06-24" @default.
• W1989892009 creator A5010114692 @default.
• W1989892009 creator A5010339413 @default.
• W1989892009 creator A5032916732 @default.
• W1989892009 creator A5053525416 @default.
• W1989892009 creator A5077447987 @default.
• W1989892009 date "2012-04-15" @default.
• W1989892009 modified "2023-09-27" @default.
• W1989892009 title "Abstract 3489: Genistein inhibits highly proliferative hematopoietic stem cells" @default.
• W1989892009 doi "https://doi.org/10.1158/1538-7445.am2012-3489" @default.
• W1989892009 hasPublicationYear "2012" @default.
• W1989892009 type Work @default.
• W1989892009 sameAs 1989892009 @default.
• W1989892009 citedByCount "0" @default.
• W1989892009 crossrefType "proceedings-article" @default.
• W1989892009 hasAuthorship W1989892009A5010114692 @default.
• W1989892009 hasAuthorship W1989892009A5010339413 @default.
• W1989892009 hasAuthorship W1989892009A5032916732 @default.
• W1989892009 hasAuthorship W1989892009A5053525416 @default.
• W1989892009 hasAuthorship W1989892009A5077447987 @default.
• W1989892009 hasConcept C109159458 @default.
• W1989892009 hasConcept C126322002 @default.
• W1989892009 hasConcept C143425029 @default.
• W1989892009 hasConcept C153911025 @default.
• W1989892009 hasConcept C203014093 @default.
• W1989892009 hasConcept C2778298627 @default.
• W1989892009 hasConcept C2778729363 @default.
• W1989892009 hasConcept C2780007613 @default.
• W1989892009 hasConcept C28328180 @default.
• W1989892009 hasConcept C2908647359 @default.
• W1989892009 hasConcept C502942594 @default.
• W1989892009 hasConcept C54355233 @default.
• W1989892009 hasConcept C552990157 @default.
• W1989892009 hasConcept C62112901 @default.
• W1989892009 hasConcept C71924100 @default.
• W1989892009 hasConcept C86803240 @default.
• W1989892009 hasConcept C95444343 @default.
• W1989892009 hasConcept C98274493 @default.
• W1989892009 hasConcept C99454951 @default.
• W1989892009 hasConceptScore W1989892009C109159458 @default.
• W1989892009 hasConceptScore W1989892009C126322002 @default.
• W1989892009 hasConceptScore W1989892009C143425029 @default.
• W1989892009 hasConceptScore W1989892009C153911025 @default.
• W1989892009 hasConceptScore W1989892009C203014093 @default.
• W1989892009 hasConceptScore W1989892009C2778298627 @default.
• W1989892009 hasConceptScore W1989892009C2778729363 @default.
• W1989892009 hasConceptScore W1989892009C2780007613 @default.
• W1989892009 hasConceptScore W1989892009C28328180 @default.
• W1989892009 hasConceptScore W1989892009C2908647359 @default.
• W1989892009 hasConceptScore W1989892009C502942594 @default.
• W1989892009 hasConceptScore W1989892009C54355233 @default.
• W1989892009 hasConceptScore W1989892009C552990157 @default.
• W1989892009 hasConceptScore W1989892009C62112901 @default.
• W1989892009 hasConceptScore W1989892009C71924100 @default.
• W1989892009 hasConceptScore W1989892009C86803240 @default.
• W1989892009 hasConceptScore W1989892009C95444343 @default.
• W1989892009 hasConceptScore W1989892009C98274493 @default.
• W1989892009 hasConceptScore W1989892009C99454951 @default.
• W1989892009 hasLocation W19898920091 @default.
• W1989892009 hasOpenAccess W1989892009 @default.
• W1989892009 hasPrimaryLocation W19898920091 @default.
• W1989892009 hasRelatedWork W189668032 @default.
• W1989892009 hasRelatedWork W2367825598 @default.
• W1989892009 hasRelatedWork W2482900659 @default.
• W1989892009 hasRelatedWork W2512064655 @default.
• W1989892009 hasRelatedWork W2512642900 @default.
• W1989892009 hasRelatedWork W2557048928 @default.
• W1989892009 hasRelatedWork W2559792829 @default.
• W1989892009 hasRelatedWork W2588162777 @default.
• W1989892009 hasRelatedWork W2589693864 @default.
• W1989892009 hasRelatedWork W2592143385 @default.
• W1989892009 hasRelatedWork W2592204585 @default.
• W1989892009 hasRelatedWork W2739555700 @default.
• W1989892009 hasRelatedWork W2787157299 @default.
• W1989892009 hasRelatedWork W2787868133 @default.
• W1989892009 hasRelatedWork W2979382316 @default.
• W1989892009 hasRelatedWork W2979904319 @default.
• W1989892009 hasRelatedWork W2979990185 @default.
• W1989892009 hasRelatedWork W2994553885 @default.
• W1989892009 hasRelatedWork W3176338055 @default.
• W1989892009 hasRelatedWork W2119674880 @default.
• W1989892009 isParatext "false" @default.
• W1989892009 isRetracted "false" @default.
• W1989892009 magId "1989892009" @default.
• W1989892009 workType "article" @default.